Weight loss can ease foot pain, but it can also leave you with less cushioning and looser shoes. Added padding and a better ...

A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements for people with type 2 diabetes than the leading oral semaglutide in a major clinical ...

In the first head-to-head trial of Ozempic versus Eli Lilly's new "King Kong" drug retatrutide, the next-generation drug led ...

Eli Lilly’s latest weight loss drug candidate, retatrutide, is already being talked about as a potential game changer in ...

GLP-1 medications such as Ozempic, Wegovy and Mounjaro may affect oral health indirectly through dry mouth, vomiting and acid ...

Lilly reports that retatrutide achieved greater weight loss and blood sugar reduction than Ozempic 2 mg in an 80-week type 2 ...

Popular diabetes and weight loss drugs such as Ozempic and Wegovy have been linked to a slightly increased risk of a rare condition that can cause sudden, potentially permanent vision loss. Although ...

In a head-to-head trial, participants with type 2 diabetes lost more than twice as much weight with retatrutide as with Ozempic and had a greater reduction in A1c.

Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of ...

"Ozempic feet" is an informal term describing heel pain and foot discomfort caused by the rapid loss of protective subcutaneous fat padding in the feet during GLP-1 weight loss therapy. Rapid body fat ...

Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics. Renée previously worked as senior pet ...